|
|
| November 12, 2008: Dr. Lori Mosca and Dr. C. Michael Gibson discuss results from the FIT Heart Trial |
Dr. Lori Mosca and Dr. C. Michael Gibson discuss results from the Novel Family-based
Intervention Trial to Improve Heart Health (FIT Heart)at the AHA 2008 Scientific Sessions
Disclosures for Dr. Gibson at the time of filming:
Present Research/Grant Funding
Schering Plough Corporation; Sanofi-Aventis; Baxter; FoldRx;
Genentech, Inc.; Astra Zeneca; HeartScape Technologies; Fold
Rx;
Abbott; Cardica, Inc.; Johnson & Johnson Corporation;
FibroGen, Inc.
Speakers Bureau
Schering Plough Corporation; Eli Lilly and Company; Daiichi
Sankyo Company, Inc;
Consultant
The Medicines Company; Bayer Corporation; Archemix
Corporation;
Heartscape Technologies, Inc.; Angel Medical Systems;
Schering Plough
Corporation; Portola Corporation; John & Johnson
Corporation; ICON
Medical Imaging; Jim Moran Heart and Vascular Research
Institute
Stock Ownership
My wife owns stock in HealthMarx Inc.
Royalties as a Contributor
UpToDate in Cardiovascular Medicine
Past Research/Grant Funding/Past Speakers Bureau/Past
Consulting
ActivBiotics, Inc.; Acusphere, Inc.; Astra; Sanofi-Aventis
Corporation; Bard Corporation; Boston Scientific
Corporation; Bristol
Meyers Squibb Company; British Biotech, plc.; Ciba Geigy
Corporation;
Corgentech, Inc.; COR Therapeutics; DVI Guidant Corporation;
GlaxoSmithKline; Genentech, Inc.; Merck & Co., Inc.;
Millennium
Pharmaceuticals; NIH; Pfizer; Percusurge, Inc.; Smith Kline
Beecham;
Sonus; St. Jude Medical; timi3 Systems, Inc.; Ascenta
Therapeutics,
Inc; CardioKinetix, Inc.; Eli Lilly and Company; KAI
Pharmaceuticals;
Nuvelo; INO Therapeutics, LLC; Point Biomedical Corporation;
Portola
Pharmaceuticals, Inc.; The Medicines Company; Ascenta
Therapeutics;
Atrium Medical Corporation; Biogen IDEC; PDL
Pharmaceuticals; timi3
Systems; Momenta Pharmaceuticals; Novartis Corporation;
Current disclosures for Dr. Gibson can be found at:
http://en.wikidoc.org/index.php/C._Michael_Gibson
[ Download video ] |
|
No comments have been submitted
|